Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Baxter International Inc (BAX)

Baxter International Inc (BAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What You Need To Know Ahead of Baxter International's Earnings Release

With a market cap of $10.3 billion, Baxter International Inc. (BAX) provides a broad portfolio of medical products, pharmaceuticals, and healthcare technologies used across hospitals, clinics, and home care settings. Operating through three segments: Medical Products and Therapies; Healthcare Systems and Technologies; and Pharmaceuticals, it serves patients and providers worldwide through an extensive international presence and distribution network.

The Deerfield, Illinois-based company is expected to unveil its fiscal Q4 2025 results soon. Ahead of the event, analysts forecast BAX to post an adjusted EPS of $0.53, a decline of 8.6% from $0.58 in the same quarter last year. It has surpassed...

Fundamentals

See More
  • Market Capitalization, $K 10,337,667
  • Shares Outstanding, K 514,056
  • Annual Sales, $ 10,636 M
  • Annual Income, $ -649,000 K
  • EBIT $ 280 M
  • EBITDA $ 1,752 M
  • 60-Month Beta 0.59
  • Price/Sales 0.94
  • Price/Cash Flow 4.23
  • Price/Book 1.43

Options Overview Details

View History
  • Implied Volatility 52.95% (+5.58%)
  • Historical Volatility 30.28%
  • IV Percentile 91%
  • IV Rank 28.29%
  • IV High 129.94% on 11/04/25
  • IV Low 22.58% on 03/25/25
  • Expected Move (DTE 3) 0.51 (2.63%)
  • Put/Call Vol Ratio 3.47
  • Today's Volume 5,285
  • Volume Avg (30-Day) 6,965
  • Put/Call OI Ratio 1.33
  • Today's Open Interest 133,359
  • Open Int (30-Day) 142,256
  • Expected Range 18.87 to 19.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.53
  • Number of Estimates 8
  • High Estimate 0.55
  • Low Estimate 0.52
  • Prior Year 0.58
  • Growth Rate Est. (year over year) -8.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.65 +3.91%
on 12/23/25
21.25 -8.80%
on 01/09/26
+0.42 (+2.22%)
since 12/19/25
3-Month
17.40 +11.38%
on 11/20/25
23.49 -17.48%
on 10/22/25
-3.75 (-16.21%)
since 10/20/25
52-Week
17.40 +11.38%
on 11/20/25
37.74 -48.65%
on 03/10/25
-11.60 (-37.44%)
since 01/17/25

Most Recent Stories

More News
What You Need To Know Ahead of Baxter International's Earnings Release

Baxter International is set to announce its fourth-quarter results soon, with analysts predicting a single-digit decline in the company's earnings.

XLV : 155.40 (-0.22%)
$SPX : 6,796.86 (-2.06%)
BAX : 19.38 (-3.63%)
1 Stock Under $50 with Impressive Fundamentals and 2 We Question

1 Stock Under $50 with Impressive Fundamentals and 2 We Question

CPRT : 40.71 (-0.80%)
BAX : 19.38 (-3.63%)
FIBK : 36.11 (-2.01%)
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Versatile, scalable design allows a range of procedures to be performed in-stretcher, reducing the need for unnecessary patient transfers Integrates advanced,...

BAX : 19.38 (-3.63%)
Why Baxter (BAX) Stock Is Trading Lower Today

Why Baxter (BAX) Stock Is Trading Lower Today

BAX : 19.38 (-3.63%)
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered...

BAX : 19.38 (-3.63%)
Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter’s president and chief executive...

BAX : 19.38 (-3.63%)
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: ...

BAX : 19.38 (-3.63%)
Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX

The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX ) for violations of §§10(b) and 20(a)...

BAX : 19.38 (-3.63%)
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options...

BAX : 19.38 (-3.63%)
Investors who lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class Action - BAX

NEW YORK , Dec. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). 

BAX : 19.38 (-3.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery,...

See More

Key Turning Points

3rd Resistance Point 20.34
2nd Resistance Point 20.14
1st Resistance Point 19.76
Last Price 19.38
1st Support Level 19.18
2nd Support Level 18.98
3rd Support Level 18.60

See More

52-Week High 37.74
Fibonacci 61.8% 29.97
Fibonacci 50% 27.57
Fibonacci 38.2% 25.17
Last Price 19.38
52-Week Low 17.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar